This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Kyto Technology and Life Science Valuation
Is KBPH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KBPH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate KBPH's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate KBPH's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KBPH?
Key metric: As KBPH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for KBPH. This is calculated by dividing KBPH's market cap by their current
earnings.
What is KBPH's PE Ratio?
PE Ratio
25.1x
Earnings
US$651.61k
Market Cap
US$16.33m
KBPH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: KBPH is good value based on its Price-To-Earnings Ratio (25.1x) compared to the US Capital Markets industry average (27.1x).
Price to Earnings Ratio vs Fair Ratio
What is KBPH's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
KBPH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
25.1x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KBPH's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.